MK-8435-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-8435-001, covering 2016-12-13 to 2016-12-13. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001) [Phase 2]